These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5677940)

  • 41. Ribonucleoside reactivities with singlet ( 1 g) molecular oxygen.
    Clagett DC; Galen TJ
    Arch Biochem Biophys; 1971 Sep; 146(1):196-201. PubMed ID: 5144025
    [No Abstract]   [Full Text] [Related]  

  • 42. Purine nucleosides. XXVII. The synthesis of 1- and 7-methyl-8-oxoguanosine and related nucleosides. The use of the N-amino group as a selective blocking agent in nucleoside synthesis.
    Rizkalla BH; Robins RK; Broom AD
    Biochim Biophys Acta; 1969 Dec; 195(2):285-93. PubMed ID: 5366921
    [No Abstract]   [Full Text] [Related]  

  • 43. Tumour-growth inhibiting substances of plant origin. II. The experimental animal tumour-pharmacology of arctigenin-mustard.
    Dombradi GA
    Chemotherapy; 1970; 15(4):250-65. PubMed ID: 5472842
    [No Abstract]   [Full Text] [Related]  

  • 44. Antitumor properties of 1,3-oxazine derivatives. Derivatives of dihydro-1,3-oxazine condensed with an aromatic ring in position 5,6.
    Mordarski M; Chylińska JB
    Arch Immunol Ther Exp (Warsz); 1971; 19(4):533-45. PubMed ID: 5095072
    [No Abstract]   [Full Text] [Related]  

  • 45. Mass spectrometry of 7-methylpurine nucleosides: studies of a characteristic oxygen incorporation reaction that occurs during trimethylsilylation.
    Von Minden DL; Stillwell RN; Koenig WA; Lyman KJ; McCloskey JA
    Anal Biochem; 1972 Nov; 50(1):110-21. PubMed ID: 5080722
    [No Abstract]   [Full Text] [Related]  

  • 46. Enzymatic phosphorylation of sangivamycin.
    Hardesty CT; Chaney NA; Waravdekar VS; Mead JA
    Biochim Biophys Acta; 1969 Dec; 195(2):581-3. PubMed ID: 5366940
    [No Abstract]   [Full Text] [Related]  

  • 47. Aminoacyl nucleosides. VII. N-(Purin-6-ylcarbamoyl)threonine. A new component of transfer ribonucleic acid.
    Schweizer MP; Chheda GB; Baczynskyj L; Hall RH
    Biochemistry; 1969 Aug; 8(8):3283-9. PubMed ID: 4897334
    [No Abstract]   [Full Text] [Related]  

  • 48. [Nucleoside as an antineoplastic agent].
    Ikehara M; Ubasawa S
    Saishin Igaku; 1970 May; 25(5):1028-38. PubMed ID: 4912176
    [No Abstract]   [Full Text] [Related]  

  • 49. Syntheses, antitumor activity and vascular relaxing effect of purino[7,8-g]-6-azapteridines and [1,2,4]triazino-[3,2-f]purines.
    Ueda T; Adachi T; Sakakibara J; Asano M; Nakagami J
    Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4031-8. PubMed ID: 3435936
    [No Abstract]   [Full Text] [Related]  

  • 50. Tissue culture screening of purines and purine nucleosides for selective damage to mouse sarcoma cells.
    BIESELE JJ; BERGER RE; CLARKE M
    Cancer Res; 1952 Jun; 12(6):399-406. PubMed ID: 14936003
    [No Abstract]   [Full Text] [Related]  

  • 51. SYNTHESIS OF POTENTIAL ANTICANCER AGENTS. XXX. (1-AZIRIDINYL)PURINES.
    MONTGOMERY JA; HEWSON K; TEMPLE C
    J Med Pharm Chem; 1962 Jan; 5():15-24. PubMed ID: 14046603
    [No Abstract]   [Full Text] [Related]  

  • 52. Resarch on new Schiff bases with antiblastic activity. Carcinostatic activities of 3-p-(2',5'-dimethoxy-4'-(N,N-bis( -chloroethyl)-amino)benzylideneamino)phenyl-2-oxazolidinone (GEA 29 = BAY a 5850).
    Pütter J; Maral R; Bierling R; Steinhoff D
    Farmaco Sci; 1971 Sep; 26(9):784-804. PubMed ID: 5157546
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of sulfur containing purine nucleosides on immunological reaction in mice. I. Immunosuppressive effect of several alkylthio, aralkylthio and thiocyanatopurines and their ribonucleosides.
    Sekine T; Arai Y; Saneyoshi M
    Jpn J Exp Med; 1973 Oct; 43(5):369-75. PubMed ID: 4544070
    [No Abstract]   [Full Text] [Related]  

  • 54. Ultra-violet extinction coefficients of some muscle nucleotides and purines at pH 7.0 and in 2N hydrochloric acid.
    Ratcliff PW; Follett MJ
    Nature; 1966 Mar; 209(5028):1129-30. PubMed ID: 5925193
    [No Abstract]   [Full Text] [Related]  

  • 55. PURINE N-OXIDES. 13. KINETICS OF THE PHOTOCHEMICAL ALTERATION OF ADENINE 1-N-OXIDE.
    LEVIN G; SETLOW RB; BROWN GB
    Biochemistry; 1964 Jul; 3():883-4. PubMed ID: 14214071
    [No Abstract]   [Full Text] [Related]  

  • 56. Structure of gliocladic acid.
    Itoh Y; Takahashi S; Arai M
    J Antibiot (Tokyo); 1982 Apr; 35(4):541-2. PubMed ID: 7096211
    [No Abstract]   [Full Text] [Related]  

  • 57. TRIMETHYLPURIN-6-YLAMMONIUM CHLORIDE.
    WHITE FR
    Cancer Chemother Rep; 1963 Jul; 30():57-9. PubMed ID: 14051506
    [No Abstract]   [Full Text] [Related]  

  • 58. Hydrogen bonding specificity of nucleic acid purines and pyrimidines in solution.
    Kyogoku Y; Lord RC; Rich A
    Science; 1966 Oct; 154(3748):518-20. PubMed ID: 5916945
    [No Abstract]   [Full Text] [Related]  

  • 59. Antitumor properties of 1,3-oxazine derivatives. I. Derivatives of 5-nitrotetrahydro-1,3-oxazines.
    Mordarski M; Chylińska B; Urbański T
    Arch Immunol Ther Exp (Warsz); 1970; 18(6):679-99. PubMed ID: 5493086
    [No Abstract]   [Full Text] [Related]  

  • 60. The treatment of experimental mouse hemoblastosis IV. Thearapy of leukemia L 14 AKR with drugs of demonstrated or potential cytostatic effects.
    Motycka K; Soucek J
    Neoplasma; 1965; 12(5):517-24. PubMed ID: 4159186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.